IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
Facebook Twitter LinkedIn Potomac, MD, March 20, 2024 – IGC Pharma, Inc. (“IGC Pharma”, “IGC”, or the “Company”) (NYSE American: IGC) today announced that Ram Mukunda, CEO, and Claudia Grimaldi, Vice President, will participate in a fire chat at the BENZINGA VIRTUAL HEALTHCARE SUMMIT 2024 (https://www.benzinga.com/events/virtual-healthcare-summit-2024/). Benzinga virtual healthcare summit 2024 will be held on […]
IGC Pharma Reports Third Quarter Fiscal 2024 Results
Facebook Twitter LinkedIn POTOMAC, MD. February 16, 2024 / IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024 ended December 31, 2023 (Q3 FY 2024). Q3 FY2024 Highlights On October 18, 2023, the European Patent Office (“EPO”) issued a patent (#3193862) to […]
IGC Pharma Announces Participation in Biotech Showcase and BioPartnering @ JPM Alongside the J.P. Morgan 41st Annual Healthcare Conference 2024
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 – Facebook Twitter LinkedIn POTOMAC, MD. December 13, 2023 / IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced that the Company’s management team will participate in Biotech Showcase and BIO Partnering @ JPM, held in-person and scheduled alongside […]
IGC Pharma Announces Collaboration to Integrate AI into Clinical Trials
– IGC Pharma to Discuss AI Partnership and Initiatives at Biotech Showcase 2024 – Facebook Twitter LinkedIn POTOMAC, MD. December 6, 2023 / IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced an Artificial Intelligence (AI) collaboration with Los Andes University’s Center for Research and Training in Artificial Intelligence (“CINFONIA”). The partnership […]